Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM)
Механизмы резистентности и современные варианты лечения мультиформной глиобластомы (GBM)
2023-04-01
SCID: 54.1/56dts685
Discuss with AI
Blood-brain barrierGlioblastoma multiformeImmune checkpoint inhibitorsTherapy resistanceTumor-treating fields
Figures from the paper
Abstract (AI)
Glioblastoma multiforme (GBM) is a highly aggressive form of brain cancer that is difficult to treat due to its resistance to both radiation and chemotherapy. This resistance is largely due to the unique biology of GBM cells, which can evade the effects of conventional treatments through mechanisms such as increased resistance to cell death and rapid regeneration of cancerous cells. Additionally, the blood-brain barrier makes it difficult for chemotherapy drugs to reach GBM cells, leading to reduced effectiveness. Despite these challenges, there are several treatment options available for GBM. The standard of care for newly diagnosed GBM patients involves surgical resection followed by concurrent chemoradiotherapy and adjuvant chemotherapy. Emerging treatments include immunotherapy, such as checkpoint inhibitors, and targeted therapies, such as bevacizumab, that attempt to attack specific vulnerabilities in GBM cells. Another promising approach is the use of tumor-treating fields, a type of electric field therapy that has been shown to slow the growth of GBM cells. Clinical trials are ongoing to evaluate the safety and efficacy of these and other innovative treatments for GBM, intending to improve with outcomes for patients.
Key Findings
1
Emerging approaches include checkpoint-inhibitor immunotherapy, targeted therapy with bevacizumab, and tumor-treating fields.
2
GBM resists radiation and chemotherapy through enhanced resistance to cell death and rapid regeneration of cancerous cells.
3
Standard treatment for newly diagnosed GBM consists of surgical resection followed by concurrent chemoradiotherapy and adjuvant chemotherapy.
4
The blood-brain barrier limits chemotherapy delivery to GBM cells, reducing treatment effectiveness.
5
Tumor-treating fields have been shown to slow GBM cell growth, while ongoing clinical trials assess innovative treatments’ safety and efficacy.
Research Object
Glioblastoma multiforme (GBM) cells and tumors
Research Subject
Mechanisms of resistance to radiation and chemotherapy and the effectiveness of current and emerging treatments
Publication Details
Publication Date
2023-04-01
Journal
Publisher
ISSN
Cited by
346
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest